News & Press Releases
Filter by:
Moderna, Arbutus Settle Covid Jab Dispute
March 4, 2026
Sige Gutman, Life Sciences Litigation Practice Chair, was quoted in an IAM article about global patent litigation settlement in Arbutus v. Moderna surrounding COVID-19 vaccine technology.
Three Mintz attorneys have been ranked in Legal 500’s US City Elite guide. The ranking honors lawyers working at the top of the legal market in their cities, states, or regions across the United States.
Mintz advised the underwriters in connection with Larimar Therapeutics’ $115 million public offering.
Members Esteban Morales and Arameh O'Boyle published an article in Bloomberg Law predicting consumer class actions will increase due to evolving state and federal laws affecting telemarketing, online privacy, product labeling, and auto-renewal practices. The authors advise businesses to closely monitor these developments and strengthen arbitration clauses and class action waivers to reduce litigation risk.
An article by Edmund Daley, Pete Michaels, and Elizabeth Platonova about a new FINRA Regulatory Notice was published by Law360. The article discusses key changes that the notice presents, including shifting a significant burden to member firms to determine when the use of negative consent is appropriate.
Mintz has been named a finalist for three awards by LSPN. The awards celebrate excellence across the industry, from trailblazing individuals to firms redefining the boundaries of life sciences IP.
